Oral contraceptive use and increased plasma concentration of C-reactive protein.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveLack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depressionMultiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study.Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle.C-reactive protein gene variants: independent association with late-life depression and circulating protein levelsCombined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: results from the Danish Blood Donor Study (DBDS).Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.Association between serum levels of C-reactive protein and personality traits in women.Positive association between 25-hydroxyvitamin D and C-reactive protein is confounded by hormonal contraceptive useGender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome.Serum Markers of Inflammation and Endothelial Function are Elevated by Hormonal Contraceptive Use but not by Exercise-Associated Menstrual Disorders in Physically Active Young Women.C-reactive protein at the interface between innate immunity and inflammation.Association of cardiorespiratory fitness and adiposity with inflammatory biomarkers in young adults.Gender-specific association between pulse pressure and C-reactive protein in a Chinese population.Obesity and Age-Related Changes in Markers of Oxidative Stress and Inflammation Across Four Generations.Low-grade inflammation is associated with lower haemoglobin levels in healthy individuals: results from the Danish blood donor study.Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives.Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.Adiposity in childhood is related to C-reactive protein and adiponectin in young adulthood: from the Bogalusa Heart Study.Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study.Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response.Body weight and oral contraceptives are the most important modulators of serum CRP levels.Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
P2860
Q24594814-5324D90F-B5A4-4DF8-84EA-1115B6F579A2Q33854590-6DB3FFCE-6F4C-4FEF-9F5C-9ECDFD462FF4Q33925293-80DEF508-6227-4E83-A934-0978623CC7CFQ34746357-5A8631A7-C107-42A9-9D20-E49F5990868CQ35034809-25AA7CD4-0F0A-4B0A-8433-D60190231E63Q35091611-BA08EFA0-6694-46EE-B081-2B455EB57FA1Q35844355-B77D969A-EDD7-4D97-BB75-F1CDC04BF60CQ36639766-A1C4C71E-857B-4540-A086-CBB9E14F00DAQ36842132-E4549AA2-2573-4CC6-9C70-F3C125874595Q37000534-95FDC591-BD75-488E-B08A-1B6C2B11BF02Q37307097-A4322E28-74DE-47F0-AB23-94190056D9A5Q37754545-41968F3C-291F-4684-8EF8-F25694EEEA3AQ39017029-E184E1F4-5E0C-45DB-B8F8-55A5F2560F73Q39706288-7D3B16E5-0F91-4042-914A-A2F15CA18CBCQ40769551-349600B1-2131-4F7E-887F-432CCC8474C5Q40868241-395D0B16-C53A-4009-8972-6ADFFDA50A64Q42369820-E04071BD-8E4C-48E9-AD7E-E77B3EC0C8D8Q44833296-6620DC60-80E1-41F5-95AD-FB89BBA33974Q46160956-EABE2CCE-9F8E-4C87-AFBF-BC2857FC45D5Q46765270-65229008-EFDD-4C62-A994-586B8810251CQ46892234-409651C8-FD66-4236-856F-A6F0E1115A51Q47270591-678A0DE0-B420-4BCB-8A73-4D59919FAED8Q47722395-A71AB1B7-89AB-4EDC-9DC3-74EB7CE207B1
P2860
Oral contraceptive use and increased plasma concentration of C-reactive protein.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Oral contraceptive use and increased plasma concentration of C-reactive protein.
@en
Oral contraceptive use and increased plasma concentration of C-reactive protein.
@nl
type
label
Oral contraceptive use and increased plasma concentration of C-reactive protein.
@en
Oral contraceptive use and increased plasma concentration of C-reactive protein.
@nl
prefLabel
Oral contraceptive use and increased plasma concentration of C-reactive protein.
@en
Oral contraceptive use and increased plasma concentration of C-reactive protein.
@nl
P1433
P1476
Oral contraceptive use and increased plasma concentration of C-reactive protein
@en
P2093
Darlene M Dreon
Joanne L Slavin
P304
P356
10.1016/S0024-3205(03)00425-9
P407
P577
2003-07-01T00:00:00Z